| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/04/2004 | WO2004018623A2 Substrates for isolating, reacting and microscopically analyzing materials |
| 03/04/2004 | WO2004018621A2 Method for determining gene knockout strategies |
| 03/04/2004 | WO2004018518A1 Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
| 03/04/2004 | WO2004018515A2 T-cell epitopes in erythropoietin |
| 03/04/2004 | WO2004018513A1 Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells |
| 03/04/2004 | WO2004018512A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 03/04/2004 | WO2004018511A2 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/04/2004 | WO2004018510A1 Marker for cancer |
| 03/04/2004 | WO2004018418A2 Hydrophilic chemiluminescent acridinium labeling reagents |
| 03/04/2004 | WO2004018100A2 A testing device for testing or analysing fluids and a holder and a storage container for such devices |
| 03/04/2004 | WO2004017997A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | WO2004017995A1 Preventive and/or therapeutic drugs for itch |
| 03/04/2004 | WO2004017983A1 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017922A2 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | WO2004017909A2 Methods of reducing ischemic injury |
| 03/04/2004 | WO2004017900A2 Assay for thrombocytopenia associated with administration of platelet gpiib-iiia receptor antagonists |
| 03/04/2004 | WO2004017895A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 03/04/2004 | WO2004017816A2 Methods for diagnosing dementia-related neurological disorders |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2004017728A2 Methods |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2004008153A3 Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr) |
| 03/04/2004 | WO2004005926A3 5t4 antigen expression as a marker for stem cell differentiation |
| 03/04/2004 | WO2004003563A3 Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases |
| 03/04/2004 | WO2004001420A3 Method and reagent for specifically identifying and quantifying one or more proteins in a sample |
| 03/04/2004 | WO2003102578A3 High throughput cellular response assay using microarrays |
| 03/04/2004 | WO2003102572A3 Mass spectrometry |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003097856A3 Plating media |
| 03/04/2004 | WO2003096391A3 System and method for controlling wafer temperature |
| 03/04/2004 | WO2003096014A3 Magneto-controlled method and system for determining an analyte in a liquid medium |
| 03/04/2004 | WO2003093815B1 Chemical structural and compositional yields model for predicting hydrocarbon thermolysis products |
| 03/04/2004 | WO2003093323A3 Automated sequential injection analysis systems for the determination of trace endotoxin levels |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
| 03/04/2004 | WO2003087395A3 Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions |
| 03/04/2004 | WO2003084480A3 HAUSP-p53 INTERACTION AND USES THEREOF |
| 03/04/2004 | WO2003083485A3 Protein for use in hypoxia related conditions |
| 03/04/2004 | WO2003082216A9 Neuroprotectant methods, compositions, and screening methods thereof |
| 03/04/2004 | WO2003081256A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21) |
| 03/04/2004 | WO2003078603A3 Strong gene sets for glioma classification |
| 03/04/2004 | WO2003074996A3 Method and device for analyzing molten masses |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003065044A3 Diagnostics and therapeutics for diseases associated with gpr72 |
| 03/04/2004 | WO2003062830A3 Fibronectin variants and screening methods |
| 03/04/2004 | WO2003062446A9 Mrp9 and its use detecting and treating cancer |
| 03/04/2004 | WO2003058239A3 Test strip for determining concentration of triglycerides |
| 03/04/2004 | WO2003056335A3 Micro-recess array for size-dependent sorting or separation of cells suspended in a flowing medium and method for analysing the functional activity of individual cells |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003051912A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/04/2004 | WO2003050526A3 Gas sensor and method for the detection of hydrogen according to the principle of work function measurement, and method for the production of such a gas sensor |
| 03/04/2004 | WO2003050292A3 Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma |
| 03/04/2004 | WO2003048301A3 Anti-hla-dr antibodies and the methods of using thereof |
| 03/04/2004 | WO2003044054A3 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 03/04/2004 | WO2003042656A3 Identifying and reducing the allergenicity of food proteins |
| 03/04/2004 | WO2003040409A9 Novel germinal center kinase proteins, compositions, and methods of use |
| 03/04/2004 | WO2003032108A3 Confirmation sequencing |
| 03/04/2004 | WO2003031981A3 Kit for predicting binding of a specific antibody to a potential immunogen and method of screening |
| 03/04/2004 | WO2003031565A3 Integrated system and method for analysis of genomic sequence data |
| 03/04/2004 | WO2003025213A3 Yeast proteome analysis |
| 03/04/2004 | WO2003023571A3 Methods for differential cell counts including related apparatus and software for performing same |
| 03/04/2004 | WO2003019198A3 Methods relating to treatment of atherosclerosis |
| 03/04/2004 | WO2003019196A3 Diagnosis and treatment of atherosclerosis |
| 03/04/2004 | WO2003012108A3 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds |
| 03/04/2004 | WO2003012034A9 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/04/2004 | WO2003010999A3 Waterless vessel heating system and method |
| 03/04/2004 | WO2003008928A9 Sensor device and method for qualitative and quantitative analysis of gas phase substances |
| 03/04/2004 | WO2003006999A3 System and method for aqueous solubility prediction |
| 03/04/2004 | WO2003001213A9 Total protein detection methods and devices at low ph |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002103052B1 Amplifiable probe |
| 03/04/2004 | WO2002101387A3 A non invasive method for screening and diagnosis fetal aneuploidies |
| 03/04/2004 | WO2002097703A9 Method to identify constituent proteins by peptides profiling |
| 03/04/2004 | WO2002095415A3 Assay ofisomerised and/or optically inverted proteins and protein fragments |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002090565A3 Magnetic beads and uses thereof |
| 03/04/2004 | WO2002085791A3 Pcr-based monitoring in wastewater biotreatment systems |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002073373A3 Ensemble-based strategy for the design of protein pharmaceuticals |
| 03/04/2004 | WO2002072606A3 Epitope testing using hla |
| 03/04/2004 | WO2002059621A3 Regulation of transthyretin to treat obesity |
| 03/04/2004 | WO2002050550A3 Oxidised low-density lipoproteins (ldl) fractions |
| 03/04/2004 | WO2002042780A9 Apparatus and methods for separating agglutinants and disperse particles |
| 03/04/2004 | WO2002029032A3 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002010751A8 Transfer microdissection |
| 03/04/2004 | WO2002002811B1 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 03/04/2004 | WO2001073123B1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/04/2004 | US20040045046 Transgenic mammals expressing polyglutamine |
| 03/04/2004 | US20040045045 Animal model for toxicology and dose prediction |
| 03/04/2004 | US20040045042 Controlling oocytes, blocking fertility; prevention reproduction |
| 03/04/2004 | US20040045041 Means for the identification compounds capable of inhibiting karap-transduced signals |
| 03/04/2004 | US20040044436 Process and installation for separating plastics, according to type, from recycled plastic mixtures |
| 03/04/2004 | US20040044294 Skin test device |
| 03/04/2004 | US20040044191 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |